Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of carbonic anhydrase inhibitors
Claudiu T. Supuran
Clinical Science (2021) Vol. 135, Iss. 10, pp. 1233-1249
Closed Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

The importance of sulfur-containing motifs in drug design and discovery
Muhamad Mustafa, Jean‐Yves Winum
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 5, pp. 501-512
Closed Access | Times Cited: 123
The Versatility in the Applications of Dithiocarbamates
Timothy O. Ajiboye, Titilope Tinu Ajiboye, Riadh Marzouki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1317-1317
Open Access | Times Cited: 97
Carbonic anhydrases in metazoan model organisms: molecules, mechanisms, and physiology
Ashok Aspatwar, Martti Tolvanen, Harlan Barker, et al.
Physiological Reviews (2022) Vol. 102, Iss. 3, pp. 1327-1383
Closed Access | Times Cited: 80
A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer
Roberto Ronca, Claudiu T. Supuran
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189120-189120
Open Access | Times Cited: 25
Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 12, pp. 1197-1208
Closed Access | Times Cited: 72
CNS pharmacology of NKCC1 inhibitors
Wolfgang Löscher, Kai Kaila
Neuropharmacology (2021) Vol. 205, pp. 108910-108910
Open Access | Times Cited: 59
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation
Aarfa Queen, Humaira Naaz Bhutto, Mohd Yousuf, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 899-913
Closed Access | Times Cited: 58
Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach
Haytham O. Tawfik, Andrea Petreni, Claudiu T. Supuran, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114190-114190
Closed Access | Times Cited: 48
Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2478-2488
Open Access | Times Cited: 47
Selected strategies to fight pathogenic bacteria
Aiva Plotniece, Arkadij Sobolev, Claudiu T. Supuran, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 34
An overview of novel antimicrobial carbonic anhydrase inhibitors
Claudiu T. Supuran
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 897-910
Closed Access | Times Cited: 31
Carbonic anhydrase inhibition by antiviral drugs in vitro and in silico
Cüneyt Türkeş
Journal of Molecular Recognition (2023) Vol. 36, Iss. 12
Open Access | Times Cited: 26
Carbonic anhydrase versatility: from pH regulation to CO2 sensing and metabolism
Claudiu T. Supuran
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 25
Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity
Samah Higazy, Nermin Samir, Ahmed El‐Khouly, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107089-107089
Closed Access | Times Cited: 12
Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 523-532
Closed Access | Times Cited: 10
Multi- and poly-pharmacology of carbonic anhydrase inhibitors
Claudiu T. Supuran
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100004-100004
Closed Access | Times Cited: 10
Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions
Rafika El Ati, Necla Öztaşkın, Ahmet Çağan, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Open Access | Times Cited: 8
Novel Carbonic Anhydrase Inhibitors
Claudiu T. Supuran
Future Medicinal Chemistry (2021) Vol. 13, Iss. 22, pp. 1935-1937
Closed Access | Times Cited: 52
Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1702-1714
Open Access | Times Cited: 43
Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022
Sridhar Goud Nerella, Priti Singh, Mohammed Arifuddin, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 833-847
Closed Access | Times Cited: 31
Diuretics: a contemporary pharmacological classification?
Miriam C. A. Kehrenberg, Hagen S. Bachmann
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 6, pp. 619-627
Open Access | Times Cited: 29
Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
Soojung Lee, Nicolai J. Toft, Trine V. Axelsen, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 22
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 22
Click chemistry approaches for developing carbonic anhydrase inhibitors and their applications
Andrea Angeli, Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top